CONTRAST - Contrast enhanced ultrasound imaging in the diagnosis and treatment of prostate cancer (contrast). (LIFE QUALITY) (2003-01-01 - 2006-12-31) (»add to infobox)

N. N. ACADEMIC MEDICAL CENTRE AMSTERDAM, N. N. INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, N. N. INNSBRUCK MEDICAL UNIVERSITY

ACADEMIC MEDICAL CENTRE BY THE UNIVERSITY OF AMSTERDAM (NL326 - Groot-Amsterdam) (Netherlands), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR716 - Rhône) (France), MEDIZINISCHE UNIVERSITAET INNSBRUCK (AT332 - Innsbruck) (Austria)

Prostate cancer is the most common cancer in the elderly men. About 80% of all cases are diagnosed after the age of 65, and it has a major impact on the Sol. Accuracy of the current diagnostic tools available to detect prostate cancer is disappointing low. This concerted action approaches the improvement in diagnosis and treatment of prostate cancer by the coordination and dissemination of the currently performed research of the partners in the field of contrast enhanced ultrasound imaging. This action will for the first time bring together the best European groups working in this field. All partners already have made a substantial contribution to the clinical research in this field during the last years. This action will coordinate these contributions to reach a critical mass, and will disseminate the results to the professionals, the industry and the users.

PERSONS (3/3)

RELATED NAVIGATION AREA(S) (2/2)